Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Nanolattix Biotechnology Co., Ltd., explained in plain language.
This early-stage study is testing a new radioactive dye called RT01-89Zr that attaches to a protein found on many solid tumor cells. The goal is to see if it can safely and clearly show tumors on PET/CT scans. About 10 adults with advanced solid tumors will receive the dye and be…
Phase: EARLY_PHASE1 • Sponsor: Nanolattix Biotechnology Co., Ltd. • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC